The A4 study: β ‐amyloid and cognition in 4432 cognitively unimpaired adults

Predicting diagnosis and cognition with 18F-AV-1451 tau PET and structural MRI in Alzheimer's disease

(2019) Niklas Mattsson et al.   Alzheimers & Dementia

Determining clinically meaningful decline in preclinical Alzheimer disease

(2019) Philip S. Insel et al.   NEUROLOGY

Subthreshold amyloid and its biological and clinical meaning

(2019) Gérard N. Bischof et al.   NEUROLOGY

Sex, amyloid, and APOE ε4 and risk of cognitive decline in preclinical Alzheimer's disease: Findings from three well-characterized cohorts

(2018) Rachel F. Buckley et al.   Alzheimers & Dementia

Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia

(2018) Willemijn J. Jansen et al.   JAMA Psychiatry

Sex differences in Alzheimer’s disease and common neuropathologies of aging

(2018) Shahram Oveisgharan et al.   ACTA NEUROPATHOLOGICA

Regional amyloid accumulation and cognitive decline in initially amyloid-negative adults

(2018) Michelle E. Farrell et al.   NEUROLOGY

Association Between Elevated Brain Amyloid and Subsequent Cognitive Decline Among Cognitively Normal Persons

(2017) Michael C. Donohue et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Cued memory decline in biomarker-defined preclinical Alzheimer disease

(2017) Kathryn V. Papp et al.   NEUROLOGY

On the path to 2025: understanding the Alzheimer’s disease continuum

(2017) Paul S. Aisen et al.   Alzheimers Research & Therapy

Time to Amyloid Positivity and Preclinical Changes in Brain Metabolism, Atrophy, and Cognition: Evidence for Emerging Amyloid Pathology in Alzheimer's Disease

(2017) Philip S. Insel et al.   Frontiers in Neuroscience

Accelerating rates of cognitive decline and imaging markers associated with β-amyloid pathology

(2016) Philip S. Insel et al.   NEUROLOGY

Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia

(2015) Willemijn J. Jansen et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Free and cued memory in relation to biomarker-defined abnormalities in clinically normal older adults and those at risk for Alzheimer’s disease

(2015) Kathryn V. Papp et al.   NEUROPSYCHOLOGIA

Do patients with young onset Alzheimer's disease deteriorate faster than those with late onset Alzheimer's disease? A review of the literature

(2014) Karen Stanley et al.   INTERNATIONAL PSYCHOGERIATRICS

The A4 Study: Stopping AD Before Symptoms Begin?

(2014) R. A. Sperling et al.   Science Translational Medicine

The Preclinical Alzheimer Cognitive Composite

(2014) Michael C. Donohue et al.   JAMA Neurology

Performance Characteristics of Amyloid PET with Florbetapir F 18 in Patients with Alzheimer's Disease and Cognitively Normal Subjects

(2012) A. D. Joshi et al.   JOURNAL OF NUCLEAR MEDICINE

Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study

(2012) Christopher M Clark et al.   LANCET NEUROLOGY